News
Man claims he went blind after taking Ozempic, shares warning for other users
Todd Engel claims Ozempic caused his total vision loss from NAION and has filed a lawsuit against Novo Nordisk over inadequate drug warnings.
A new study suggests an RNA-based therapy could help semaglutide target more fat while reducing the lean-muscle loss associated with GLP-1 weight loss.
Discussion (0)
No comments yet. Start the conversation!